Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Tech Transfer Awards
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • NIH IRP Access Planning Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

METHOD TO INDUCE CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR A BROAD ARRAY OF HIV-1 ISOLATES USING HYBRID SYNTHETIC PEPTIDES

  • Read more about METHOD TO INDUCE CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR A BROAD ARRAY OF HIV-1 ISOLATES USING HYBRID SYNTHETIC PEPTIDES
Patent Cooperation Treaty
PCT/US1992/007714
Filed on 1992-09-18

METHOD OF DETECTING INFECTIOUS VIRUS STRAINS

  • Read more about METHOD OF DETECTING INFECTIOUS VIRUS STRAINS
Patent Cooperation Treaty
PCT/US1992/007386
Filed on 1992-09-08

ANTI-HIV PROTEINS GAP 31, DAP 30 AND DAP 32, DNA CODING THEREFOR AND THERAPEUTIC USES THEREOF

  • Read more about ANTI-HIV PROTEINS GAP 31, DAP 30 AND DAP 32, DNA CODING THEREFOR AND THERAPEUTIC USES THEREOF
Patent Cooperation Treaty
PCT/US1992/007142
Filed on 1992-08-26

EUKARYOTIC EXPRESSION VECTORS WITH REGULATION OF RNA PROCESSING

  • Read more about EUKARYOTIC EXPRESSION VECTORS WITH REGULATION OF RNA PROCESSING
Patent Cooperation Treaty
PCT/US1992/004011
Filed on 1992-05-21

Recombinant Virus Expressing Carcinoembryonic Antigen and Methods of Use Thereof

  • Read more about Recombinant Virus Expressing Carcinoembryonic Antigen and Methods of Use Thereof
Patent Cooperation Treaty
PCT/US1992/003843
Filed on 1992-05-06

MONOCLONAL ANTIBODIES FOR SPECIFIC HUMAN THYMIDYLATE SYNTHASE

  • Read more about MONOCLONAL ANTIBODIES FOR SPECIFIC HUMAN THYMIDYLATE SYNTHASE
Patent Cooperation Treaty
PCT/US1992/003114
Filed on 1992-04-24

AN ANTI-HIV PROTEIN, TAP 29, FROM TRICHOSANTHES, DNA CODING THEREFOR AND THERAPEUTIC USES THEREOF

  • Read more about AN ANTI-HIV PROTEIN, TAP 29, FROM TRICHOSANTHES, DNA CODING THEREFOR AND THERAPEUTIC USES THEREOF
Patent Cooperation Treaty
PCT/US1992/003089
Filed on 1992-04-15

ELISA Assay of Serum Soluble CD22 to Assess Tumor Burden/Relapse in Subjects with Leukemia and Lymphoma

  • Read more about ELISA Assay of Serum Soluble CD22 to Assess Tumor Burden/Relapse in Subjects with Leukemia and Lymphoma
Patent Cooperation Treaty
PCT/US03/16298
Filed on 2003-05-20

BASE, A New Cancer Gene, and Uses Thereof

  • Read more about BASE, A New Cancer Gene, and Uses Thereof
Patent Cooperation Treaty
PCT/US2003/039476
Filed on 2003-12-10

Nitric Oxide-Releasing Metallic Medical Devices

  • Read more about Nitric Oxide-Releasing Metallic Medical Devices
Patent Cooperation Treaty
PCT/US01/014407
Filed on 2001-05-04

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1483
  • Page 1484
  • Page 1485
  • Page 1486
  • Page 1487
  • Page 1488
  • Page 1489
  • Page 1490
  • Page 1491
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health